Dr Jason Roberts
Honorary Senior Fellow
Department of Infectious Diseases
945 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
DOI: 10.1038/s41541-025-01355-y2026
Journal article
Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy
DOI: 10.1186/s13054-026-06226-z2026
Journal article
Intrapulmonary penetration of ceftolozane/tazobactam and ceftazidime/avibactam administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
DOI: 10.1186/s13054-026-06075-w2026
Journal article
Pharmacokinetic and pharmacokinetic/pharmacodynamic (PK/PD) considerations of ceftaroline and ceftobiprole for the treatment of Staphylococcus aureus infections: A systematic review
DOI: 10.1016/j.ijantimicag.2026.1079592026
Journal article
Pharmacokinetics of intravenous ciprofloxacin for Legionella pneumonia during prolonged intermittent kidney replacement therapy: a case report and literature review
DOI: 10.1186/s41100-026-00738-82026
Journal article
Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review
DOI: 10.1186/s13054-026-05999-72026
Journal article
Vancomycin population pharmacokinetics and optimized dosing in critically ill infants and children
DOI: 10.1016/j.ijantimicag.2026.108006
RECENT SCHOLARLY WORKS
2026
Journal article
Antimicrobial prophylaxis regimens in joint replacement surgery: Susceptibility and PK/PD target attainment
DOI: 10.1016/j.ijantimicag.2026.1079472026
Journal article
Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment—authors’ response
DOI: 10.1093/jac/dkag3422026
Journal article
Cefazolin administration prior to caesarean delivery and breastmilk microbiome: a nested cohort within a randomised clinical trial
DOI: 10.1016/j.ijoa.2026.105222